Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Apr 26, 2014; 6(4): 154-174
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.154

Table 3 Future candidate proteins for arrhythmogenic ventricular cardiomyopathy

Encoded protein

Components of the desmosome

Plectin

Emerin

Components of the adherens junction

β-catenin

α-catenin

N-cadherin

Components of the gap junction

Connexin 43

Myotonic dystrophy protein kinase-1

Laminin receptor-1

Components of dystrophin-glycoprotein complex

Citation: Saguner AM, Brunckhorst C, Duru F. Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease. World J Cardiol 2014; 6(4): 154-174
URL: https://www.wjgnet.com/1949-8462/full/v6/i4/154.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i4.154

Saguner AM, Brunckhorst C, Duru F. Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease. World J Cardiol 2014; 6(4): 154-174 [PMID: 24772256 DOI: 10.4330/wjc.v6.i4.154]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.